First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, +14

The Lancet

Hematological MalignancyZoledronic AcidOncologyPharmacologyHematology +6

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Andy C. Rawstron, J. A. Child, Ruth M. de Tute, +12

Journal of Clinical Oncology

The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells

Yasser M. El‐Sherbiny, Josephine Meade, Tim D. Holmes, +9

Cancer Research

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, +14

Blood

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory, +15

The Lancet Oncology

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, +13

Haematologica

CD4⁺CD25⁺FoxP3⁺ regulatory T cells are increased whilst CD3⁺CD4⁻CD8⁻αβTCR⁺ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin, +6

British Journal of Haematology

Disease BurdenT-regulatory CellImmune RegulationImmunologyPathology +19

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study

Sylvia Feyler, H. Miles Prince, Rachel Pearce, +8

Bone Marrow Transplantation

Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationAbmtrr Study +10

Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent

Sylvia Feyler, Gina B. Scott, Christopher Parrish, +6

PLoS ONE

IgM myeloma: a rare entity characterized by a CD20⁻CD56⁻CD117⁻ immunophenotype and the t(11;14)

Sylvia Feyler, Sheila J.M. O’Connor, Andy C. Rawstron, +7

British Journal of Haematology

Hematological MalignancyDeletion 13ImmunogeneticsIgm MyelomaInterphase Fluorescence +13